Skip to main content
. 2024 Apr 26;10(9):e30287. doi: 10.1016/j.heliyon.2024.e30287

Table 4.

KMO inhibition (IC50) by the lead compounds.

Compound IC50 (μM) Inhibition type
3′-Hydroxy-alpha-naphthoflavone 15.85 ± 0.98 Competitive
3′-Hydroxy-ss-naphthoflavone 18.71 ± 0.78 Competitive
Genkwanin 21.61 ± 0.97 Non-competitive
Apigenin 24.14 ± 1.00 Non-competitive
Ro 61–8048 (positive control) 4.96 ± 0.31 NT (not tested)